These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 21456529

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
    Rowe MD, Chang CC, Thamm DH, Kraft SL, Harmon JF, Vogt AP, Sumerlin BS, Boyes SG.
    Langmuir; 2009 Aug 18; 25(16):9487-99. PubMed ID: 19422256
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M, Selegård L, Klasson A, Söderlind F, Abrikossova N, Skoglund C, Bengtsson T, Engström M, Käll PO, Uvdal K.
    Langmuir; 2010 Apr 20; 26(8):5753-62. PubMed ID: 20334417
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
    Riyahi-Alam N, Behrouzkia Z, Seifalian A, Haghgoo Jahromi S.
    Biol Trace Elem Res; 2010 Dec 20; 137(3):324-34. PubMed ID: 20049554
    [Abstract] [Full Text] [Related]

  • 6. MRI relaxation properties of water-soluble apoferritin-encapsulated gadolinium oxide-hydroxide nanoparticles.
    Sánchez P, Valero E, Gálvez N, Domínguez-Vera JM, Marinone M, Poletti G, Corti M, Lascialfari A.
    Dalton Trans; 2009 Feb 07; (5):800-4. PubMed ID: 19156273
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents.
    Lee N, Hyeon T.
    Chem Soc Rev; 2012 Apr 07; 41(7):2575-89. PubMed ID: 22138852
    [Abstract] [Full Text] [Related]

  • 9. Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.
    Faucher L, Tremblay M, Lagueux J, Gossuin Y, Fortin MA.
    ACS Appl Mater Interfaces; 2012 Sep 26; 4(9):4506-15. PubMed ID: 22834680
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Poly(acrylic acid) Bridged Gadolinium Metal-Organic Framework-Gold Nanoparticle Composites as Contrast Agents for Computed Tomography and Magnetic Resonance Bimodal Imaging.
    Tian C, Zhu L, Lin F, Boyes SG.
    ACS Appl Mater Interfaces; 2015 Aug 19; 7(32):17765-75. PubMed ID: 26147906
    [Abstract] [Full Text] [Related]

  • 12. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
    Park JY, Baek MJ, Choi ES, Woo S, Kim JH, Kim TJ, Jung JC, Chae KS, Chang Y, Lee GH.
    ACS Nano; 2009 Nov 24; 3(11):3663-9. PubMed ID: 19835389
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Facile synthesis and relaxation properties of novel bispolyazamacrocyclic Gd3+ complexes: an attempt towards calcium-sensitive MRI contrast agents.
    Mishra A, Fousková P, Angelovski G, Balogh E, Mishra AK, Logothetis NK, Tóth E.
    Inorg Chem; 2008 Feb 18; 47(4):1370-81. PubMed ID: 18166011
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X, Jackson EF, Price RE, Kim EE, Wu Q, Wallace S, Charnsangavej C, Gelovani JG, Li C.
    Bioconjug Chem; 2004 Feb 18; 15(6):1408-15. PubMed ID: 15546209
    [Abstract] [Full Text] [Related]

  • 16. Preparation and characterization of ZnS:Tb,Gd and ZnS:Er,Yb,Gd nanoparticles for bimodal magnetic-fluorescent imaging.
    Wei X, Wang W, Chen K.
    Dalton Trans; 2013 Feb 07; 42(5):1752-9. PubMed ID: 23160019
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nanotechnology and MRI contrast enhancement.
    Matson ML, Wilson LJ.
    Future Med Chem; 2010 Mar 07; 2(3):491-502. PubMed ID: 21426177
    [Abstract] [Full Text] [Related]

  • 19. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
    Mishra A, Pfeuffer J, Mishra R, Engelmann J, Mishra AK, Ugurbil K, Logothetis NK.
    Bioconjug Chem; 2006 Mar 07; 17(3):773-80. PubMed ID: 16704217
    [Abstract] [Full Text] [Related]

  • 20. Strategies for increasing relaxivity of gold nanoparticle based MRI contrast agents.
    Warsi MF, Chechik V.
    Phys Chem Chem Phys; 2011 May 28; 13(20):9812-7. PubMed ID: 21503280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.